- Yale Medicine Fertility Center200 West Campus DriveFl 2Orange, CT 06477
Hugh Taylor, MD
Biography
Hugh S. Taylor, MD, chair of obstetrics, gynecology and reproductive sciences, is internationally known for his studies on endometriosis. He combines the latest medical therapies with surgeries when needed to provide optimal care for women with pain or infertility related to endometriosis, a common, painful condition in which endometrial tissue grows outside the uterus.
“It’s a fascinating, but troubling disease. We don’t know what causes the lining of the uterus to grow outside it, but we’re doing research to find out why,” Dr. Taylor says. “Women can go 10 years before they are diagnosed, and we are doing a lot to speed that up.”
Another specialized condition for which Dr. Taylor receives referrals from around the country is for women with a very thin endometrium, which makes embryo implantation difficult. “These women aren’t getting pregnant, and we think the problem is not the eggs or the embryo, but that the uterus isn’t receptive to those embryos,” explains Dr. Taylor.
Complicated medical problems and the opportunity to truly help patients drew Dr. Taylor to obstetrics and gynecology. “There are so many unsolved problems that affect people from birth through the rest of their life. If you can make an impact during pregnancy or around the time of birth, you can change the whole trajectory of someone’s life,” he says. “It’s an amazing opportunity to be able to make such a difference.”
Dr. Taylor has been elected to the National Academy of Medicine, one of the nation’s highest honors in the fields of health and medicine. He is an active researcher and has been funded by the National Institutes of Health continuously for more than 20 years. A professor of obstetrics, gynecology and reproductive sciences; and of molecular, cellular and development biology at Yale School of Medicine, Dr. Taylor is also chief of obstetrics and gynecology at Yale New Haven Hospital.
Titles
- Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences and Professor of Molecular, Cellular, and Developmental Biology
- Chair, Obstetrics, Gynecology & Reproductive Sciences
- Chief , Obstetrics and Gynecology, Yale New Haven Hospital
Education & Training
- FellowYale University School of Medicine (1998)
- FellowYale University School of Medicine (1996)
- ResidentYale-New Haven Hospital (1992)
- MDUniversity of Connecticut (1988)
- BAYale University, Molecular Biophysics and Biochemistry (1983)
Additional Information
- Elected Member: Association of American Physicians (2024)
- Distinguished Scientist Award: Society for Gynecologic Investigation (2020)
- National Academy of Medicine: (2016)
- Best Research in Reproductive Medicine: IVI Foundation (2013)
- Honoree of the Year: Endometriosis Association (2012)
- AB of Obstetrics & Gynecology, Reproductive Endocrinology & Infertility (2002, recertified: 2020)
- AB of Obstetrics & Gynecology, Obstetrics & Gynecology (1999, recertified: 2020)
- President of the American Society for Reproductive Medicine (2020 - 2021): President
- President of the Society for Gynecologic Investigation (2017 - 2018): President
- Al-Lami R, Taha S, Jalloul R, Taylor H. Women with endometriosis in the United States: National Survey of Family Growth, 2011–2019. Journal Of Endometriosis And Uterine Disorders 2024, 8: 100081. DOI: 10.1016/j.jeud.2024.100081.
- Lv H, Liu B, Dai Y, Li F, Bellone S, Zhou Y, Mamillapalli R, Zhao D, Venkatachalapathy M, Hu Y, Carmichael G, Li D, Taylor H, Huang Y. TET3-overexpressing macrophages promote endometriosis. Journal Of Clinical Investigation 2024, 134: e181839. PMID: 39141428, PMCID: PMC11527447, DOI: 10.1172/jci181839.
- Flores V, Sahin C, Taylor H. Progesterone Receptor Status predicts Aggressiveness of Human Endometriotic lesions in Murine Avatars. F&S Science 2024 PMID: 39393571, DOI: 10.1016/j.xfss.2024.10.004.
- Vélez-Avilés A, Abel A, Bergmann J, Cevik E, Zhong L, Taylor H, Sozen B. ENDOMETRIAL AND IMPLANTATION MODELING UTILIZING A HIGH-THROUGHPUT 3D SPHEROID GENERATION SYSTEM. Fertility And Sterility 2024, 122: e365. DOI: 10.1016/j.fertnstert.2024.08.130.
- Mamillapalli R, Han E, Cevik E, Gawde N, Thomas K, Taylor H. IL-6 PREVENTS EXCESSIVE INVASION IN ENDOMETRIOSIS. Fertility And Sterility 2024, 122: e157-e158. DOI: 10.1016/j.fertnstert.2024.07.558.
- Flores V, Delis P, Mamillapalli R, Taylor H. THE USE OF AMD3100 FOR BONE MARROW DERIVED MESENCHYMAL STEM CELLS MOBILIZATION IN THE TREATMENT OF ASHERMAN’S SYNDROME. Fertility And Sterility 2024, 122: e36-e37. DOI: 10.1016/j.fertnstert.2024.07.168.
- Gawde N, Mamillapalli R, Taylor H. THERAPEUTIC EFFECT OF ENDOMETRIOSIS ASSOCIATED MICRO-RNAS ON HUMAN ENDOMETRIOSIS XENOTRANSPLANTS. Fertility And Sterility 2024, 122: e156-e157. DOI: 10.1016/j.fertnstert.2024.07.556.
- Garg A, Mamillapalli R, Krikun G, Habata S, Atwani R, Taylor H. A NOVEL CHIMERIC IMMUNOCONJUGATE MOLECULE (ICON3) SUPPRESSES ENDOMETRIOSIS IN A MURINE MODEL. Fertility And Sterility 2024, 122: e337-e338. DOI: 10.1016/j.fertnstert.2024.08.065.
- Younis J, Taylor H. Is There an Association Between Endometriosis, Early Menopause, and Cardiovascular Disease? The Journal Of Clinical Endocrinology & Metabolism 2024, 109: e1946-e1949. PMID: 39083665, DOI: 10.1210/clinem/dgae508.
- Li H, Esencan E, Song Y, Taylor H, Cho Y, Vash-Margita A. Medical Management of Endometriosis in Adolescent and Young Adult Women: A Review of 91 Cases of Biopsy-Confirmed Endometriosis. Journal Of Obstetrics And Gynaecology Canada 2024, 46: 102562. PMID: 38759792, DOI: 10.1016/j.jogc.2024.102562.
- Younis J, Taylor H. The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews. Frontiers In Endocrinology 2024, 15: 1397279. PMID: 38800489, PMCID: PMC11116636, DOI: 10.3389/fendo.2024.1397279.
- Bonavina G, Mamillapalli R, Krikun G, Zhou Y, Gawde N, Taylor H. Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation. Stem Cell Research & Therapy 2024, 15: 129. PMID: 38693588, PMCID: PMC11064399, DOI: 10.1186/s13287-024-03716-1.
- Donnez J, Becker C, Taylor H, Herrera F, Donnez O, Horne A, Paszkowski M, Petraglia F, Renner S, Patel A, Boolell M, Bestel E, Dolmans M. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3). Human Reproduction 2024, 39: 1208-1221. PMID: 38648863, PMCID: PMC11144970, DOI: 10.1093/humrep/deae076.
- Group T, Canis M, Abbott J, Abrao M, Al-Jefout M, Bedaiwy M, Benagiano G, Burns K, Carmona F, Chapron C, Critchley H, de Ziegler D, Falcone T, Fazleabas A, Ferrero S, Garcia-Velasco J, Gargett C, Greaves E, Griffith L, Habiba M, Harada T, Hull M, Kaufman Y, Issacson K, Khan K, Kim M, Koninckx P, Lessey B, Martin D, Matsuzaki S, Mishra G, Osuga Y, Petraglia F, Popov A, Roman H, Romano A, Seckin T, Saounders P, Somigliana E, Guo S, Taylor H, Vercellini P, Vigano P, Johnson N. Authors’ Reply. Journal Of Minimally Invasive Gynecology 2024, 31: 624-626. PMID: 38641049, DOI: 10.1016/j.jmig.2024.04.008.
- Brakta S, Du Q, Chorich L, Hawkins Z, Sullivan M, Ko E, Kim H, Knight J, Taylor H, Friez M, Phillips J, Layman L. Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Molecular And Cellular Endocrinology 2024, 589: 112237. PMID: 38599276, DOI: 10.1016/j.mce.2024.112237.
- Seli D, Prendergast A, Ergun Y, Tyagi A, Taylor H. High NaCl Concentrations in Water Are Associated with Developmental Abnormalities and Altered Gene Expression in Zebrafish. International Journal Of Molecular Sciences 2024, 25: 4104. PMID: 38612913, PMCID: PMC11012806, DOI: 10.3390/ijms25074104.
- Taylor H, Wen J. Ring Chromosome 12. 2024, 191-199. DOI: 10.1007/978-3-031-47530-6_16.
- Taylor H, Dong L, Haikonen J, Oppelt P, Tamussino K, Wenzl R, Faustmann T, Groettrup-Wolfers E, Ren X, Seitz C. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial. F&S Reports 2024, 5: 189-196. PMID: 38983729, PMCID: PMC11228778, DOI: 10.1016/j.xfre.2024.03.002.
- Donnez J, Taylor H, Marcellin L, Dolmans M. Uterine fibroid–related infertility: mechanisms and management. Fertility And Sterility 2024, 122: 31-39. PMID: 38453041, DOI: 10.1016/j.fertnstert.2024.02.049.
- Canis M, Abbott J, Abrao M, Al-Jefout M, Bedaiwy M, Benagiano G, Burns K, Canis M, Carmona F, Chapron C, Critchley H, de Ziegler D, Falcone T, Fazleabas A, Ferrero S, Garcia-Velasco J, Gargett C, Greaves E, Griffith L, Guo S, Habiba M, Harada T, Hull M, Johnson N, Kaufman Y, Issacson K, Khan K, Kim M, Koninckx P, Lessey B, Martin D, Matsuzaki S, Mishra G, Osuga Y, Petraglia F, Popov A, Roman H, Romano A, Saunders P, Seckin T, Somigliana E, Taylor H, Taylor R, Vercellini P, Vigano P. A Call for New Theories on the Pathogenesis and Pathophysiology of Endometriosis. Journal Of Minimally Invasive Gynecology 2024, 31: 371-377. PMID: 38365066, DOI: 10.1016/j.jmig.2024.02.004.
- Al-Hendy A, Segars J, Taylor H, González F, Siblini H, Zamah M, Alkelani H, Singh B, Flores V, Christman G, Johnson J, Huang H, Zhang H. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) – protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids. BMJ Open 2024, 14: e078989. PMID: 38216200, PMCID: PMC10806662, DOI: 10.1136/bmjopen-2023-078989.
- Pal L, Taylor H. Chapter 39 Role in reproductive biology and dysfunction in women. 2024, 873-888. DOI: 10.1016/b978-0-323-91386-7.00036-2.
- Lyu F, Burzynski C, Fang Y, Tal A, Chen A, Kisa J, Agrawal K, Kluger Y, Taylor H, Tal R. Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation. JCI Insight 2023, 8: e172216. PMID: 37815869, PMCID: PMC10721256, DOI: 10.1172/jci.insight.172216.
- Song J, Lv H, Liu B, Hao M, Taylor H, Zhang X, Li D, Huang Y. Let-7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF-β production. Molecular Metabolism 2023, 78: 101828. PMID: 37898449, PMCID: PMC10641683, DOI: 10.1016/j.molmet.2023.101828.
- Lyu F, Burzynski C, Chen A, Taylor H, Tal R. MATERNAL CXCR4 DELETION RESULTS IN PLACENTAL DEFECTS AND PREGNANCY LOSS MEDIATED BY IMMUNE DYSREGULATION THAT IS RESCUED BY ADOPTIVE TRANSFER OF CXCR4+ BONE MARROW CELLS. Fertility And Sterility 2023, 120: e43-e44. DOI: 10.1016/j.fertnstert.2023.08.153.
- Mamillapalli R, Golden A, Taylor H, Gawde N. TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS. Fertility And Sterility 2023, 120: e307. DOI: 10.1016/j.fertnstert.2023.08.888.
- Beroukhim G, Kayani J, Taylor H, Pal L. Examining the association between urinary triclosan levels and menopausal status: results from the National Health and Nutrition Examination Survey, 2003 to 2016. Menopause The Journal Of The North American Menopause Society 2023, 30: 906-912. PMID: 37625087, DOI: 10.1097/gme.0000000000002233.
- Saleh F, Adashi E, Sable D, Kushnir V, Taylor H. Changes to reproductive endocrinology and infertility practice, research, and training as investor mergers increase. F&S Reports 2023, 4: 332-336. PMID: 38204944, PMCID: PMC10774877, DOI: 10.1016/j.xfre.2023.08.001.
- Habata S, Mamillapalli R, Ucar A, Taylor H. Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis in Mice. Stem Cells International 2023, 2023: 1598127. PMID: 37545483, PMCID: PMC10403325, DOI: 10.1155/2023/1598127.
- Seli D, Taylor H. The impact of air pollution and endocrine disruptors on reproduction and assisted reproduction. Current Opinion In Obstetrics & Gynecology 2023, 35: 210-215. PMID: 36924404, DOI: 10.1097/gco.0000000000000868.
- Berbrier D, Leone C, Adler T, Bender J, Taylor H, Stachenfeld N, Usselman C. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome. Journal Of Applied Physiology 2023, 134: 868-878. PMID: 36861670, DOI: 10.1152/japplphysiol.00583.2022.
- Ben Ishai P, Davis D, Taylor H, Birnbaum L. Problems in evaluating the health impacts of radio frequency radiation. Environmental Research 2023, 243: 115038. PMID: 36863648, DOI: 10.1016/j.envres.2022.115038.
- Saleh F, Taylor H. Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine. F&S Reports 2023, 4: 83-87. PMID: 37223759, PMCID: PMC10201293, DOI: 10.1016/j.xfre.2023.01.008.
- Davis D, Birnbaum L, Ben-Ishai P, Taylor H, Sears M, Butler T, Scarato T. Wireless technologies, non-ionizing electromagnetic fields and children: Identifying and reducing health risks. Current Problems In Pediatric And Adolescent Health Care 2023, 53: 101374. PMID: 36935315, DOI: 10.1016/j.cppeds.2023.101374.
- Siblini H, Al-Hendy A, Segars J, González F, Taylor H, Singh B, Flaminia A, Flores V, Christman G, Huang H, Johnson J, Zhang H. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women. Nutrients 2023, 15: 320. PMID: 36678191, PMCID: PMC9861948, DOI: 10.3390/nu15020320.
- Donnez J, Taylor H, Stewart E, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland J, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E. Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. Obstetrical & Gynecological Survey 2022, 77: 741-742. DOI: 10.1097/ogx.0000000000001113.
- Esencan E, Taylor H. Gonadotropin-Releasing Hormone Antagonists Revolutionizing Gynecology. Obstetrics And Gynecology 2022, 140: 917-919. PMID: 36357969, DOI: 10.1097/aog.0000000000005012.
- Pondugula N, Sayeed S, de Queiroz Campos G, Li H, Taylor H, Cho Y. Risk of Repeat Laparoscopy Following Surgical Diagnosis of Endometriosis: Effects of Hysterectomy, Oophorectomy, & Psychiatric Disease. Journal Of Minimally Invasive Gynecology 2022, 29: s36. DOI: 10.1016/j.jmig.2022.09.118.
- Bonavina G, Taylor H. Endometriosis-associated infertility: From pathophysiology to tailored treatment. Frontiers In Endocrinology 2022, 13: 1020827. PMID: 36387918, PMCID: PMC9643365, DOI: 10.3389/fendo.2022.1020827.
- Surrey E, Xu Y, Frakes E, Scott M, Lee L, Piercy J, Taylor H. ASSESSMENT OF PATIENT-REPORTED PAIN RELIEF IN TREATED ENDOMETRIOSIS PATIENTS: FINDINGS FROM A REAL-WORLD STUDY IN THE UNITED STATES. Fertility And Sterility 2022, 118: e223-e224. DOI: 10.1016/j.fertnstert.2022.08.634.
- Mamillapalli R, Mangla A, Taylor H. EFFECT OF MICRORNAS THAT ARE LINKED TO ENDOMETRIOSIS ON HEPATIC GENE EXPRESSION. Fertility And Sterility 2022, 118: e8. DOI: 10.1016/j.fertnstert.2022.08.038.
- Donnez J, Taylor H, Gemzell-Danielsson K, Catherino W, Bestel E, Gotteland J, Humberstone A, Moore L, Garner E. O-306 LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Human Reproduction 2022, 37: deac105.103. DOI: 10.1093/humrep/deac105.103.
- Arkfeld C, Taylor H. Fertilization and Implantation. 2022, 79-107. DOI: 10.1007/978-3-030-99596-6_4.
- Berbrier D, Leone C, Adler T, Bender J, Taylor H, Stachenfeld N, Usselman C. Endothelial (Dys)function in Women With Androgen Excess Polycystic Ovary Syndrome: Effects of Body Composition and Ethinyl Estradiol Supplementation. The FASEB Journal 2022, 36 DOI: 10.1096/fasebj.2022.36.s1.0r847.
- Al-Hendy A, Taylor H, Catherino W, Stewart E, Bestel E, Garner E. Incidence of Alopecia in Treatment of Women With Uterine Fibroids: Results of Two Phase 3 Trials of Linzagolix [A104]. Obstetrics And Gynecology 2022, 139: 30s-30s. DOI: 10.1097/01.aog.0000826736.08037.1b.
- Al-Hendy A, Bradley L, Taylor H, Catherino W, Humberstone A, Garner E. Quality of Life Improvements in Women with Uterine Fibroids: Results of Two Phase 3 Trials with Linzagolix [A107]. Obstetrics And Gynecology 2022, 139: 31s-31s. DOI: 10.1097/01.aog.0000826748.26150.66.
- Taylor H, Donnez J, Bestel E, Humberstone A, Garner E. Post-treatment Efficacy and Safety Follow-up in Women with Uterine Fibroids Treated for 52 Weeks With Linzagolix [A108]. Obstetrics And Gynecology 2022, 139: 31s-32s. DOI: 10.1097/01.aog.0000826752.16466.97.
- Medicine P, Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, Jindal S, Kalra S, Mersereau J, Reindollar R, Shannon C, Steiner A, Tanrikut C, Taylor H, Yauger B. Obesity and reproduction: a committee opinion. Fertility And Sterility 2021, 116: 1266-1285. PMID: 34583840, DOI: 10.1016/j.fertnstert.2021.08.018.
- Beroukhim G, Kayani J, Taylor H, Pal L. ASSOCIATION BETWEEN URINARY TRICLOSAN LEVELS AND AGE OF MENARCHE: ANALYSES OF NHANES (2003-2016) DATA. Fertility And Sterility 2021, 116: e406. DOI: 10.1016/j.fertnstert.2021.07.1084.
- Engmann L, Sun F, Legro RS, Diamond MP, Zhang H, Santoro N, Bartlebaugh C, Dodson W, Estes S, Ober J, Brzyski R, Easton C, Hernandez A, Leija M, Pierce D, Robinson R, Awonuga A, Cedo L, Cline A, Collins K, Krawetz S, Puscheck E, Singh M, Yoscovits M, Barnhart K, Coutifaris C, Lecks K, Martino L, Marunich R, Snyder P, Alvero R, Comfort A, Crow M, Schlaff W, Casson P, Hohmann A, Mallette S, Christman G, Ohl D, Ringbloom M, Tang J, Bates G, Mason S, DiMaria N, Usadi R, Lucidi R, Rhea M, Baker V, Turner K, Trussell J, DelBasso D, Huang H, Li Y, Makuch R, Patrizio P, Sakai L, Scahill L, Taylor H, Thomas T, Tsang S, Yan Q, Zhang M, Haisenleder D, Lamar C, DePaolo L, Herring A, Redmond J, Thomas M, Turek P, Wactawski-Wende J, Rebar R, Cato P, Dukic V, Lewis V, Schlegel P, Witter F. Factors associated with study protocol adherence and bio banking participation in reproductive medicine clinical trials and their relationship to live birth. Human Reproduction 2020, 35: 2819-2831. PMID: 33190149, PMCID: PMC8453415, DOI: 10.1093/humrep/deaa232.
- Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Internal Medicine 2017, 177: 1471-1479. PMID: 28846767, PMCID: PMC5710212, DOI: 10.1001/jamainternmed.2017.3877.
- Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. New England Journal Of Medicine 2017, 377: 28-40. PMID: 28525302, DOI: 10.1056/nejmoa1700089.
- Adler T, Usselman C, Anaeto L, Schapiro R, Steele F, Toffoloni N, Takamata A, Taylor H, Stachenfeld N. Relationship between body mass index and endothelial dysfunction in women with and without polycystic ovary syndrome. The FASEB Journal 2017, 31 DOI: 10.1096/fasebj.31.1_supplement.691.8.
- Usselman C, Taylor H, Stachenfeld N. Microvascular endothelial function in lean versus obese women with polycystic ovary syndrome: role of the endothelin B receptor. The FASEB Journal 2017, 31 DOI: 10.1096/fasebj.31.1_supplement.691.5.
- Grechukhina O, Petracco R, Popkhadze S, Massasa E, Paranjape T, Chan E, Flores I, Weidhaas JB, Taylor HS. A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosis. EMBO Molecular Medicine 2012, 4: 206-217. PMID: 22307873, PMCID: PMC3376847, DOI: 10.1002/emmm.201100200.
- Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ. Novel Therapies Targeting Endometriosis. Reproductive Sciences 2011, 18: 814-823. PMID: 21693775, PMCID: PMC4046304, DOI: 10.1177/1933719111410713.
- Santamaria X, Massasa EE, Feng Y, Wolff E, Taylor HS. Derivation of Insulin Producing Cells From Human Endometrial Stromal Stem Cells and Use in the Treatment of Murine Diabetes. Molecular Therapy 2011, 19: 2065-2071. PMID: 21878900, PMCID: PMC3222529, DOI: 10.1038/mt.2011.173.
- Kulak J, Fischer C, Komm B, Taylor HS. Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model. Endocrinology 2011, 152: 3226-3232. PMID: 21586552, PMCID: PMC3138238, DOI: 10.1210/en.2010-1010.
- Wolff EF, Gao X, Yao KV, Andrews ZB, Du H, Elsworth JD, Taylor HS. Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model. Journal Of Cellular And Molecular Medicine 2011, 15: 747-755. PMID: 20406327, PMCID: PMC2998585, DOI: 10.1111/j.1582-4934.2010.01068.x.
- Martin JR, Lieber SB, McGrath J, Shanabrough M, Horvath TL, Taylor HS. Maternal Ghrelin Deficiency Compromises Reproduction in Female Progeny through Altered Uterine Developmental Programming. Endocrinology 2011, 152: 2060-2066. PMID: 21325042, PMCID: PMC3075930, DOI: 10.1210/en.2010-1485.
- Zhou Y, Gan Y, Taylor HS. Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus. Reproductive Toxicology 2010, 31: 123-127. PMID: 20955787, PMCID: PMC3207965, DOI: 10.1016/j.reprotox.2010.10.007.
- Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Human Reproduction Update 2010, 17: 242-253. PMID: 20729534, PMCID: PMC3039220, DOI: 10.1093/humupd/dmq037.
- Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. The FASEB Journal 2010, 24: 2273-2280. PMID: 20181937, PMCID: PMC3230522, DOI: 10.1096/fj.09-140533.
- Andikyan V, Taylor HS. WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type. Journal Of Cellular And Molecular Medicine 2009, 13: 4522-4531. PMID: 19017365, PMCID: PMC3107857, DOI: 10.1111/j.1582-4934.2008.00574.x.
- Bromer JG, Wu J, Zhou Y, Taylor HS. Hypermethylation of Homeobox A10 by in Utero Diethylstilbestrol Exposure: An Epigenetic Mechanism for Altered Developmental Programming. Endocrinology 2009, 150: 3376-3382. PMID: 19299448, PMCID: PMC2703508, DOI: 10.1210/en.2009-0071.
- Lee B, Du H, Taylor HS. Experimental Murine Endometriosis Induces DNA Methylation and Altered Gene Expression in Eutopic Endometrium1. Biology Of Reproduction 2008, 80: 79-85. PMID: 18799756, PMCID: PMC2804809, DOI: 10.1095/biolreprod.108.070391.
- Connell KA, Guess MK, Chen H, Andikyan V, Bercik R, Taylor HS. HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. Journal Of Clinical Investigation 2008, 118: 1050-1055. PMID: 18274672, PMCID: PMC2242622, DOI: 10.1172/jci34193.
- Wolff EF, Wolff AB, Hongling Du, Taylor HS. Demonstration of Multipotent Stem Cells in the Adult Human Endometrium by In Vitro Chondrogenesis. Reproductive Sciences 2007, 14: 524-533. PMID: 17959881, DOI: 10.1177/1933719107306896.
- Du H, Taylor HS. Contribution of Bone Marrow‐Derived Stem Cells to Endometrium and Endometriosis. Stem Cells 2007, 25: 2082-2086. PMID: 17464086, DOI: 10.1634/stemcells.2006-0828.
- Martin R, Taylor MB, Krikun G, Lockwood C, Akbas GE, Taylor HS. Differential Cell-Specific Modulation of HOXA10 by Estrogen and Specificity Protein 1 Response Elements. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 1920-1926. PMID: 17311863, DOI: 10.1210/jc.2006-1694.
- Smith CC, Taylor HS. Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. The FASEB Journal 2006, 21: 239-246. PMID: 17093138, DOI: 10.1096/fj.06-6635com.
- Taylor HS. Endometrial Cells Derived From Donor Stem Cells in Bone Marrow Transplant Recipients. JAMA 2004, 292: 81-85. PMID: 15238594, DOI: 10.1001/jama.292.1.81.
- Troy PJ, Daftary GS, Bagot CN, Taylor HS. Transcriptional Repression of Peri-Implantation EMX2 Expression in Mammalian Reproduction by HOXA10. Molecular And Cellular Biology 2003, 23: 1-13. PMID: 12482956, PMCID: PMC140663, DOI: 10.1128/mcb.23.1.1-13.2003.
- Taylor H. Sex Steroids Mediate HOXA11 Expression in the Human Peri-Implantation Endometrium. The Journal Of Clinical Endocrinology & Metabolism 1999, 84: 1129-1135. DOI: 10.1210/jc.84.3.1129.
- Yale Medicine Fertility Center200 West Campus DriveFl 2Orange, CT 06477
Biography
Hugh S. Taylor, MD, chair of obstetrics, gynecology and reproductive sciences, is internationally known for his studies on endometriosis. He combines the latest medical therapies with surgeries when needed to provide optimal care for women with pain or infertility related to endometriosis, a common, painful condition in which endometrial tissue grows outside the uterus.
“It’s a fascinating, but troubling disease. We don’t know what causes the lining of the uterus to grow outside it, but we’re doing research to find out why,” Dr. Taylor says. “Women can go 10 years before they are diagnosed, and we are doing a lot to speed that up.”
Another specialized condition for which Dr. Taylor receives referrals from around the country is for women with a very thin endometrium, which makes embryo implantation difficult. “These women aren’t getting pregnant, and we think the problem is not the eggs or the embryo, but that the uterus isn’t receptive to those embryos,” explains Dr. Taylor.
Complicated medical problems and the opportunity to truly help patients drew Dr. Taylor to obstetrics and gynecology. “There are so many unsolved problems that affect people from birth through the rest of their life. If you can make an impact during pregnancy or around the time of birth, you can change the whole trajectory of someone’s life,” he says. “It’s an amazing opportunity to be able to make such a difference.”
Dr. Taylor has been elected to the National Academy of Medicine, one of the nation’s highest honors in the fields of health and medicine. He is an active researcher and has been funded by the National Institutes of Health continuously for more than 20 years. A professor of obstetrics, gynecology and reproductive sciences; and of molecular, cellular and development biology at Yale School of Medicine, Dr. Taylor is also chief of obstetrics and gynecology at Yale New Haven Hospital.
Titles
- Anita O'Keeffe Young Professor of Obstetrics, Gynecology, and Reproductive Sciences and Professor of Molecular, Cellular, and Developmental Biology
- Chair, Obstetrics, Gynecology & Reproductive Sciences
- Chief , Obstetrics and Gynecology, Yale New Haven Hospital
Education & Training
- FellowYale University School of Medicine (1998)
- FellowYale University School of Medicine (1996)
- ResidentYale-New Haven Hospital (1992)
- MDUniversity of Connecticut (1988)
- BAYale University, Molecular Biophysics and Biochemistry (1983)
Additional Information
- Elected Member: Association of American Physicians (2024)
- Distinguished Scientist Award: Society for Gynecologic Investigation (2020)
- National Academy of Medicine: (2016)
- Best Research in Reproductive Medicine: IVI Foundation (2013)
- Honoree of the Year: Endometriosis Association (2012)
- AB of Obstetrics & Gynecology, Reproductive Endocrinology & Infertility (2002, recertified: 2020)
- AB of Obstetrics & Gynecology, Obstetrics & Gynecology (1999, recertified: 2020)
- President of the American Society for Reproductive Medicine (2020 - 2021): President
- President of the Society for Gynecologic Investigation (2017 - 2018): President
- Al-Lami R, Taha S, Jalloul R, Taylor H. Women with endometriosis in the United States: National Survey of Family Growth, 2011–2019. Journal Of Endometriosis And Uterine Disorders 2024, 8: 100081. DOI: 10.1016/j.jeud.2024.100081.
- Lv H, Liu B, Dai Y, Li F, Bellone S, Zhou Y, Mamillapalli R, Zhao D, Venkatachalapathy M, Hu Y, Carmichael G, Li D, Taylor H, Huang Y. TET3-overexpressing macrophages promote endometriosis. Journal Of Clinical Investigation 2024, 134: e181839. PMID: 39141428, PMCID: PMC11527447, DOI: 10.1172/jci181839.
- Flores V, Sahin C, Taylor H. Progesterone Receptor Status predicts Aggressiveness of Human Endometriotic lesions in Murine Avatars. F&S Science 2024 PMID: 39393571, DOI: 10.1016/j.xfss.2024.10.004.
- Vélez-Avilés A, Abel A, Bergmann J, Cevik E, Zhong L, Taylor H, Sozen B. ENDOMETRIAL AND IMPLANTATION MODELING UTILIZING A HIGH-THROUGHPUT 3D SPHEROID GENERATION SYSTEM. Fertility And Sterility 2024, 122: e365. DOI: 10.1016/j.fertnstert.2024.08.130.
- Mamillapalli R, Han E, Cevik E, Gawde N, Thomas K, Taylor H. IL-6 PREVENTS EXCESSIVE INVASION IN ENDOMETRIOSIS. Fertility And Sterility 2024, 122: e157-e158. DOI: 10.1016/j.fertnstert.2024.07.558.
- Flores V, Delis P, Mamillapalli R, Taylor H. THE USE OF AMD3100 FOR BONE MARROW DERIVED MESENCHYMAL STEM CELLS MOBILIZATION IN THE TREATMENT OF ASHERMAN’S SYNDROME. Fertility And Sterility 2024, 122: e36-e37. DOI: 10.1016/j.fertnstert.2024.07.168.
- Gawde N, Mamillapalli R, Taylor H. THERAPEUTIC EFFECT OF ENDOMETRIOSIS ASSOCIATED MICRO-RNAS ON HUMAN ENDOMETRIOSIS XENOTRANSPLANTS. Fertility And Sterility 2024, 122: e156-e157. DOI: 10.1016/j.fertnstert.2024.07.556.
- Garg A, Mamillapalli R, Krikun G, Habata S, Atwani R, Taylor H. A NOVEL CHIMERIC IMMUNOCONJUGATE MOLECULE (ICON3) SUPPRESSES ENDOMETRIOSIS IN A MURINE MODEL. Fertility And Sterility 2024, 122: e337-e338. DOI: 10.1016/j.fertnstert.2024.08.065.
- Younis J, Taylor H. Is There an Association Between Endometriosis, Early Menopause, and Cardiovascular Disease? The Journal Of Clinical Endocrinology & Metabolism 2024, 109: e1946-e1949. PMID: 39083665, DOI: 10.1210/clinem/dgae508.
- Li H, Esencan E, Song Y, Taylor H, Cho Y, Vash-Margita A. Medical Management of Endometriosis in Adolescent and Young Adult Women: A Review of 91 Cases of Biopsy-Confirmed Endometriosis. Journal Of Obstetrics And Gynaecology Canada 2024, 46: 102562. PMID: 38759792, DOI: 10.1016/j.jogc.2024.102562.
- Younis J, Taylor H. The impact of ovarian endometrioma and endometriotic cystectomy on anti-Müllerian hormone, and antral follicle count: a contemporary critical appraisal of systematic reviews. Frontiers In Endocrinology 2024, 15: 1397279. PMID: 38800489, PMCID: PMC11116636, DOI: 10.3389/fendo.2024.1397279.
- Bonavina G, Mamillapalli R, Krikun G, Zhou Y, Gawde N, Taylor H. Bone marrow mesenchymal stem cell-derived exosomes shuttle microRNAs to endometrial stromal fibroblasts that promote tissue proliferation /regeneration/ and inhibit differentiation. Stem Cell Research & Therapy 2024, 15: 129. PMID: 38693588, PMCID: PMC11064399, DOI: 10.1186/s13287-024-03716-1.
- Donnez J, Becker C, Taylor H, Herrera F, Donnez O, Horne A, Paszkowski M, Petraglia F, Renner S, Patel A, Boolell M, Bestel E, Dolmans M. Linzagolix therapy versus a placebo in patients with endometriosis-associated pain: a prospective, randomized, double-blind, Phase 3 study (EDELWEISS 3). Human Reproduction 2024, 39: 1208-1221. PMID: 38648863, PMCID: PMC11144970, DOI: 10.1093/humrep/deae076.
- Group T, Canis M, Abbott J, Abrao M, Al-Jefout M, Bedaiwy M, Benagiano G, Burns K, Carmona F, Chapron C, Critchley H, de Ziegler D, Falcone T, Fazleabas A, Ferrero S, Garcia-Velasco J, Gargett C, Greaves E, Griffith L, Habiba M, Harada T, Hull M, Kaufman Y, Issacson K, Khan K, Kim M, Koninckx P, Lessey B, Martin D, Matsuzaki S, Mishra G, Osuga Y, Petraglia F, Popov A, Roman H, Romano A, Seckin T, Saounders P, Somigliana E, Guo S, Taylor H, Vercellini P, Vigano P, Johnson N. Authors’ Reply. Journal Of Minimally Invasive Gynecology 2024, 31: 624-626. PMID: 38641049, DOI: 10.1016/j.jmig.2024.04.008.
- Brakta S, Du Q, Chorich L, Hawkins Z, Sullivan M, Ko E, Kim H, Knight J, Taylor H, Friez M, Phillips J, Layman L. Heterozygous ZNHIT3 variants within the 17q12 recurrent deletion region are associated with Mayer-Rokitansky-Kuster Hauser (MRKH) syndrome. Molecular And Cellular Endocrinology 2024, 589: 112237. PMID: 38599276, DOI: 10.1016/j.mce.2024.112237.
- Seli D, Prendergast A, Ergun Y, Tyagi A, Taylor H. High NaCl Concentrations in Water Are Associated with Developmental Abnormalities and Altered Gene Expression in Zebrafish. International Journal Of Molecular Sciences 2024, 25: 4104. PMID: 38612913, PMCID: PMC11012806, DOI: 10.3390/ijms25074104.
- Taylor H, Wen J. Ring Chromosome 12. 2024, 191-199. DOI: 10.1007/978-3-031-47530-6_16.
- Taylor H, Dong L, Haikonen J, Oppelt P, Tamussino K, Wenzl R, Faustmann T, Groettrup-Wolfers E, Ren X, Seitz C. Vilaprisan for the treatment of symptomatic endometriosis: results from a terminated phase 2b randomized controlled trial. F&S Reports 2024, 5: 189-196. PMID: 38983729, PMCID: PMC11228778, DOI: 10.1016/j.xfre.2024.03.002.
- Donnez J, Taylor H, Marcellin L, Dolmans M. Uterine fibroid–related infertility: mechanisms and management. Fertility And Sterility 2024, 122: 31-39. PMID: 38453041, DOI: 10.1016/j.fertnstert.2024.02.049.
- Canis M, Abbott J, Abrao M, Al-Jefout M, Bedaiwy M, Benagiano G, Burns K, Canis M, Carmona F, Chapron C, Critchley H, de Ziegler D, Falcone T, Fazleabas A, Ferrero S, Garcia-Velasco J, Gargett C, Greaves E, Griffith L, Guo S, Habiba M, Harada T, Hull M, Johnson N, Kaufman Y, Issacson K, Khan K, Kim M, Koninckx P, Lessey B, Martin D, Matsuzaki S, Mishra G, Osuga Y, Petraglia F, Popov A, Roman H, Romano A, Saunders P, Seckin T, Somigliana E, Taylor H, Taylor R, Vercellini P, Vigano P. A Call for New Theories on the Pathogenesis and Pathophysiology of Endometriosis. Journal Of Minimally Invasive Gynecology 2024, 31: 371-377. PMID: 38365066, DOI: 10.1016/j.jmig.2024.02.004.
- Al-Hendy A, Segars J, Taylor H, González F, Siblini H, Zamah M, Alkelani H, Singh B, Flores V, Christman G, Johnson J, Huang H, Zhang H. Fibroids and unexplained infertility treatment with epigallocatechin gallate: a natural compound in green tea (FRIEND) – protocol for a randomised placebo-controlled US multicentre clinical trial of EGCG to improve fertility in women with uterine fibroids. BMJ Open 2024, 14: e078989. PMID: 38216200, PMCID: PMC10806662, DOI: 10.1136/bmjopen-2023-078989.
- Pal L, Taylor H. Chapter 39 Role in reproductive biology and dysfunction in women. 2024, 873-888. DOI: 10.1016/b978-0-323-91386-7.00036-2.
- Lyu F, Burzynski C, Fang Y, Tal A, Chen A, Kisa J, Agrawal K, Kluger Y, Taylor H, Tal R. Maternal CXCR4 deletion results in placental defects and pregnancy loss mediated by immune dysregulation. JCI Insight 2023, 8: e172216. PMID: 37815869, PMCID: PMC10721256, DOI: 10.1172/jci.insight.172216.
- Song J, Lv H, Liu B, Hao M, Taylor H, Zhang X, Li D, Huang Y. Let-7 suppresses liver fibrosis by inhibiting hepatocyte apoptosis and TGF-β production. Molecular Metabolism 2023, 78: 101828. PMID: 37898449, PMCID: PMC10641683, DOI: 10.1016/j.molmet.2023.101828.
- Lyu F, Burzynski C, Chen A, Taylor H, Tal R. MATERNAL CXCR4 DELETION RESULTS IN PLACENTAL DEFECTS AND PREGNANCY LOSS MEDIATED BY IMMUNE DYSREGULATION THAT IS RESCUED BY ADOPTIVE TRANSFER OF CXCR4+ BONE MARROW CELLS. Fertility And Sterility 2023, 120: e43-e44. DOI: 10.1016/j.fertnstert.2023.08.153.
- Mamillapalli R, Golden A, Taylor H, Gawde N. TARGETING PD1/PD-L1/PD-L2 SIGNALING IN ENDOMETRIOSIS. Fertility And Sterility 2023, 120: e307. DOI: 10.1016/j.fertnstert.2023.08.888.
- Beroukhim G, Kayani J, Taylor H, Pal L. Examining the association between urinary triclosan levels and menopausal status: results from the National Health and Nutrition Examination Survey, 2003 to 2016. Menopause The Journal Of The North American Menopause Society 2023, 30: 906-912. PMID: 37625087, DOI: 10.1097/gme.0000000000002233.
- Saleh F, Adashi E, Sable D, Kushnir V, Taylor H. Changes to reproductive endocrinology and infertility practice, research, and training as investor mergers increase. F&S Reports 2023, 4: 332-336. PMID: 38204944, PMCID: PMC10774877, DOI: 10.1016/j.xfre.2023.08.001.
- Habata S, Mamillapalli R, Ucar A, Taylor H. Donor Mesenchymal Stem Cells Program Bone Marrow, Altering Macrophages, and Suppressing Endometriosis in Mice. Stem Cells International 2023, 2023: 1598127. PMID: 37545483, PMCID: PMC10403325, DOI: 10.1155/2023/1598127.
- Seli D, Taylor H. The impact of air pollution and endocrine disruptors on reproduction and assisted reproduction. Current Opinion In Obstetrics & Gynecology 2023, 35: 210-215. PMID: 36924404, DOI: 10.1097/gco.0000000000000868.
- Berbrier D, Leone C, Adler T, Bender J, Taylor H, Stachenfeld N, Usselman C. Effects of androgen excess and body mass index on endothelial function in women with polycystic ovary syndrome. Journal Of Applied Physiology 2023, 134: 868-878. PMID: 36861670, DOI: 10.1152/japplphysiol.00583.2022.
- Ben Ishai P, Davis D, Taylor H, Birnbaum L. Problems in evaluating the health impacts of radio frequency radiation. Environmental Research 2023, 243: 115038. PMID: 36863648, DOI: 10.1016/j.envres.2022.115038.
- Saleh F, Taylor H. Clinical applications of gonadotropin-releasing hormone analogues: a broad impact on reproductive medicine. F&S Reports 2023, 4: 83-87. PMID: 37223759, PMCID: PMC10201293, DOI: 10.1016/j.xfre.2023.01.008.
- Davis D, Birnbaum L, Ben-Ishai P, Taylor H, Sears M, Butler T, Scarato T. Wireless technologies, non-ionizing electromagnetic fields and children: Identifying and reducing health risks. Current Problems In Pediatric And Adolescent Health Care 2023, 53: 101374. PMID: 36935315, DOI: 10.1016/j.cppeds.2023.101374.
- Siblini H, Al-Hendy A, Segars J, González F, Taylor H, Singh B, Flaminia A, Flores V, Christman G, Huang H, Johnson J, Zhang H. Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women. Nutrients 2023, 15: 320. PMID: 36678191, PMCID: PMC9861948, DOI: 10.3390/nu15020320.
- Donnez J, Taylor H, Stewart E, Bradley L, Marsh E, Archer D, Al-Hendy A, Petraglia F, Watts N, Gotteland J, Bestel E, Terrill P, Loumaye E, Humberstone A, Garner E. Linzagolix With and Without Hormonal Add-Back Therapy for the Treatment of Symptomatic Uterine Fibroids: Two Randomized, Placebo-Controlled, Phase 3 Trials. Obstetrical & Gynecological Survey 2022, 77: 741-742. DOI: 10.1097/ogx.0000000000001113.
- Esencan E, Taylor H. Gonadotropin-Releasing Hormone Antagonists Revolutionizing Gynecology. Obstetrics And Gynecology 2022, 140: 917-919. PMID: 36357969, DOI: 10.1097/aog.0000000000005012.
- Pondugula N, Sayeed S, de Queiroz Campos G, Li H, Taylor H, Cho Y. Risk of Repeat Laparoscopy Following Surgical Diagnosis of Endometriosis: Effects of Hysterectomy, Oophorectomy, & Psychiatric Disease. Journal Of Minimally Invasive Gynecology 2022, 29: s36. DOI: 10.1016/j.jmig.2022.09.118.
- Bonavina G, Taylor H. Endometriosis-associated infertility: From pathophysiology to tailored treatment. Frontiers In Endocrinology 2022, 13: 1020827. PMID: 36387918, PMCID: PMC9643365, DOI: 10.3389/fendo.2022.1020827.
- Surrey E, Xu Y, Frakes E, Scott M, Lee L, Piercy J, Taylor H. ASSESSMENT OF PATIENT-REPORTED PAIN RELIEF IN TREATED ENDOMETRIOSIS PATIENTS: FINDINGS FROM A REAL-WORLD STUDY IN THE UNITED STATES. Fertility And Sterility 2022, 118: e223-e224. DOI: 10.1016/j.fertnstert.2022.08.634.
- Mamillapalli R, Mangla A, Taylor H. EFFECT OF MICRORNAS THAT ARE LINKED TO ENDOMETRIOSIS ON HEPATIC GENE EXPRESSION. Fertility And Sterility 2022, 118: e8. DOI: 10.1016/j.fertnstert.2022.08.038.
- Donnez J, Taylor H, Gemzell-Danielsson K, Catherino W, Bestel E, Gotteland J, Humberstone A, Moore L, Garner E. O-306 LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. Human Reproduction 2022, 37: deac105.103. DOI: 10.1093/humrep/deac105.103.
- Arkfeld C, Taylor H. Fertilization and Implantation. 2022, 79-107. DOI: 10.1007/978-3-030-99596-6_4.
- Berbrier D, Leone C, Adler T, Bender J, Taylor H, Stachenfeld N, Usselman C. Endothelial (Dys)function in Women With Androgen Excess Polycystic Ovary Syndrome: Effects of Body Composition and Ethinyl Estradiol Supplementation. The FASEB Journal 2022, 36 DOI: 10.1096/fasebj.2022.36.s1.0r847.
- Al-Hendy A, Taylor H, Catherino W, Stewart E, Bestel E, Garner E. Incidence of Alopecia in Treatment of Women With Uterine Fibroids: Results of Two Phase 3 Trials of Linzagolix [A104]. Obstetrics And Gynecology 2022, 139: 30s-30s. DOI: 10.1097/01.aog.0000826736.08037.1b.
- Al-Hendy A, Bradley L, Taylor H, Catherino W, Humberstone A, Garner E. Quality of Life Improvements in Women with Uterine Fibroids: Results of Two Phase 3 Trials with Linzagolix [A107]. Obstetrics And Gynecology 2022, 139: 31s-31s. DOI: 10.1097/01.aog.0000826748.26150.66.
- Taylor H, Donnez J, Bestel E, Humberstone A, Garner E. Post-treatment Efficacy and Safety Follow-up in Women with Uterine Fibroids Treated for 52 Weeks With Linzagolix [A108]. Obstetrics And Gynecology 2022, 139: 31s-32s. DOI: 10.1097/01.aog.0000826752.16466.97.
- Medicine P, Penzias A, Azziz R, Bendikson K, Falcone T, Hansen K, Hill M, Jindal S, Kalra S, Mersereau J, Reindollar R, Shannon C, Steiner A, Tanrikut C, Taylor H, Yauger B. Obesity and reproduction: a committee opinion. Fertility And Sterility 2021, 116: 1266-1285. PMID: 34583840, DOI: 10.1016/j.fertnstert.2021.08.018.
- Beroukhim G, Kayani J, Taylor H, Pal L. ASSOCIATION BETWEEN URINARY TRICLOSAN LEVELS AND AGE OF MENARCHE: ANALYSES OF NHANES (2003-2016) DATA. Fertility And Sterility 2021, 116: e406. DOI: 10.1016/j.fertnstert.2021.07.1084.
- Engmann L, Sun F, Legro RS, Diamond MP, Zhang H, Santoro N, Bartlebaugh C, Dodson W, Estes S, Ober J, Brzyski R, Easton C, Hernandez A, Leija M, Pierce D, Robinson R, Awonuga A, Cedo L, Cline A, Collins K, Krawetz S, Puscheck E, Singh M, Yoscovits M, Barnhart K, Coutifaris C, Lecks K, Martino L, Marunich R, Snyder P, Alvero R, Comfort A, Crow M, Schlaff W, Casson P, Hohmann A, Mallette S, Christman G, Ohl D, Ringbloom M, Tang J, Bates G, Mason S, DiMaria N, Usadi R, Lucidi R, Rhea M, Baker V, Turner K, Trussell J, DelBasso D, Huang H, Li Y, Makuch R, Patrizio P, Sakai L, Scahill L, Taylor H, Thomas T, Tsang S, Yan Q, Zhang M, Haisenleder D, Lamar C, DePaolo L, Herring A, Redmond J, Thomas M, Turek P, Wactawski-Wende J, Rebar R, Cato P, Dukic V, Lewis V, Schlegel P, Witter F. Factors associated with study protocol adherence and bio banking participation in reproductive medicine clinical trials and their relationship to live birth. Human Reproduction 2020, 35: 2819-2831. PMID: 33190149, PMCID: PMC8453415, DOI: 10.1093/humrep/deaa232.
- Taylor HS, Tal A, Pal L, Li F, Black DM, Brinton EA, Budoff MJ, Cedars MI, Du W, Hodis HN, Lobo RA, Manson JE, Merriam GR, Miller VM, Naftolin F, Neal-Perry G, Santoro NF, Harman SM. Effects of Oral vs Transdermal Estrogen Therapy on Sexual Function in Early Postmenopause: Ancillary Study of the Kronos Early Estrogen Prevention Study (KEEPS). JAMA Internal Medicine 2017, 177: 1471-1479. PMID: 28846767, PMCID: PMC5710212, DOI: 10.1001/jamainternmed.2017.3877.
- Taylor HS, Giudice LC, Lessey BA, Abrao MS, Kotarski J, Archer DF, Diamond MP, Surrey E, Johnson NP, Watts NB, Gallagher JC, Simon JA, Carr BR, Dmowski WP, Leyland N, Rowan JP, Duan WR, Ng J, Schwefel B, Thomas JW, Jain RI, Chwalisz K. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist. New England Journal Of Medicine 2017, 377: 28-40. PMID: 28525302, DOI: 10.1056/nejmoa1700089.
- Adler T, Usselman C, Anaeto L, Schapiro R, Steele F, Toffoloni N, Takamata A, Taylor H, Stachenfeld N. Relationship between body mass index and endothelial dysfunction in women with and without polycystic ovary syndrome. The FASEB Journal 2017, 31 DOI: 10.1096/fasebj.31.1_supplement.691.8.
- Usselman C, Taylor H, Stachenfeld N. Microvascular endothelial function in lean versus obese women with polycystic ovary syndrome: role of the endothelin B receptor. The FASEB Journal 2017, 31 DOI: 10.1096/fasebj.31.1_supplement.691.5.
- Grechukhina O, Petracco R, Popkhadze S, Massasa E, Paranjape T, Chan E, Flores I, Weidhaas JB, Taylor HS. A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosis. EMBO Molecular Medicine 2012, 4: 206-217. PMID: 22307873, PMCID: PMC3376847, DOI: 10.1002/emmm.201100200.
- Taylor HS, Osteen KG, Bruner-Tran KL, Lockwood CJ, Krikun G, Sokalska A, Duleba AJ. Novel Therapies Targeting Endometriosis. Reproductive Sciences 2011, 18: 814-823. PMID: 21693775, PMCID: PMC4046304, DOI: 10.1177/1933719111410713.
- Santamaria X, Massasa EE, Feng Y, Wolff E, Taylor HS. Derivation of Insulin Producing Cells From Human Endometrial Stromal Stem Cells and Use in the Treatment of Murine Diabetes. Molecular Therapy 2011, 19: 2065-2071. PMID: 21878900, PMCID: PMC3222529, DOI: 10.1038/mt.2011.173.
- Kulak J, Fischer C, Komm B, Taylor HS. Treatment with Bazedoxifene, a Selective Estrogen Receptor Modulator, Causes Regression of Endometriosis in a Mouse Model. Endocrinology 2011, 152: 3226-3232. PMID: 21586552, PMCID: PMC3138238, DOI: 10.1210/en.2010-1010.
- Wolff EF, Gao X, Yao KV, Andrews ZB, Du H, Elsworth JD, Taylor HS. Endometrial stem cell transplantation restores dopamine production in a Parkinson’s disease model. Journal Of Cellular And Molecular Medicine 2011, 15: 747-755. PMID: 20406327, PMCID: PMC2998585, DOI: 10.1111/j.1582-4934.2010.01068.x.
- Martin JR, Lieber SB, McGrath J, Shanabrough M, Horvath TL, Taylor HS. Maternal Ghrelin Deficiency Compromises Reproduction in Female Progeny through Altered Uterine Developmental Programming. Endocrinology 2011, 152: 2060-2066. PMID: 21325042, PMCID: PMC3075930, DOI: 10.1210/en.2010-1485.
- Zhou Y, Gan Y, Taylor HS. Cigarette smoke inhibits recruitment of bone-marrow-derived stem cells to the uterus. Reproductive Toxicology 2010, 31: 123-127. PMID: 20955787, PMCID: PMC3207965, DOI: 10.1016/j.reprotox.2010.10.007.
- Cakmak H, Taylor HS. Implantation failure: molecular mechanisms and clinical treatment. Human Reproduction Update 2010, 17: 242-253. PMID: 20729534, PMCID: PMC3039220, DOI: 10.1093/humupd/dmq037.
- Bromer JG, Zhou Y, Taylor MB, Doherty L, Taylor HS. Bisphenol‐A exposure in utero leads to epigenetic alterations in the developmental programming of uterine estrogen response. The FASEB Journal 2010, 24: 2273-2280. PMID: 20181937, PMCID: PMC3230522, DOI: 10.1096/fj.09-140533.
- Andikyan V, Taylor HS. WT1 represses HOX gene expression in the regulation of gynaecologic tumour histologic type. Journal Of Cellular And Molecular Medicine 2009, 13: 4522-4531. PMID: 19017365, PMCID: PMC3107857, DOI: 10.1111/j.1582-4934.2008.00574.x.
- Bromer JG, Wu J, Zhou Y, Taylor HS. Hypermethylation of Homeobox A10 by in Utero Diethylstilbestrol Exposure: An Epigenetic Mechanism for Altered Developmental Programming. Endocrinology 2009, 150: 3376-3382. PMID: 19299448, PMCID: PMC2703508, DOI: 10.1210/en.2009-0071.
- Lee B, Du H, Taylor HS. Experimental Murine Endometriosis Induces DNA Methylation and Altered Gene Expression in Eutopic Endometrium1. Biology Of Reproduction 2008, 80: 79-85. PMID: 18799756, PMCID: PMC2804809, DOI: 10.1095/biolreprod.108.070391.
- Connell KA, Guess MK, Chen H, Andikyan V, Bercik R, Taylor HS. HOXA11 is critical for development and maintenance of uterosacral ligaments and deficient in pelvic prolapse. Journal Of Clinical Investigation 2008, 118: 1050-1055. PMID: 18274672, PMCID: PMC2242622, DOI: 10.1172/jci34193.
- Wolff EF, Wolff AB, Hongling Du, Taylor HS. Demonstration of Multipotent Stem Cells in the Adult Human Endometrium by In Vitro Chondrogenesis. Reproductive Sciences 2007, 14: 524-533. PMID: 17959881, DOI: 10.1177/1933719107306896.
- Du H, Taylor HS. Contribution of Bone Marrow‐Derived Stem Cells to Endometrium and Endometriosis. Stem Cells 2007, 25: 2082-2086. PMID: 17464086, DOI: 10.1634/stemcells.2006-0828.
- Martin R, Taylor MB, Krikun G, Lockwood C, Akbas GE, Taylor HS. Differential Cell-Specific Modulation of HOXA10 by Estrogen and Specificity Protein 1 Response Elements. The Journal Of Clinical Endocrinology & Metabolism 2007, 92: 1920-1926. PMID: 17311863, DOI: 10.1210/jc.2006-1694.
- Smith CC, Taylor HS. Xenoestrogen exposure imprints expression of genes (Hoxa10) required for normal uterine development. The FASEB Journal 2006, 21: 239-246. PMID: 17093138, DOI: 10.1096/fj.06-6635com.
- Taylor HS. Endometrial Cells Derived From Donor Stem Cells in Bone Marrow Transplant Recipients. JAMA 2004, 292: 81-85. PMID: 15238594, DOI: 10.1001/jama.292.1.81.
- Troy PJ, Daftary GS, Bagot CN, Taylor HS. Transcriptional Repression of Peri-Implantation EMX2 Expression in Mammalian Reproduction by HOXA10. Molecular And Cellular Biology 2003, 23: 1-13. PMID: 12482956, PMCID: PMC140663, DOI: 10.1128/mcb.23.1.1-13.2003.
- Taylor H. Sex Steroids Mediate HOXA11 Expression in the Human Peri-Implantation Endometrium. The Journal Of Clinical Endocrinology & Metabolism 1999, 84: 1129-1135. DOI: 10.1210/jc.84.3.1129.
- Yale Medicine Fertility Center200 West Campus DriveFl 2Orange, CT 06477
- Yale Medicine Fertility Center200 West Campus DriveFl 2Orange, CT 06477